Dr Jackie Fairley, Starpharma CEO, commented: “We are delighted to be submitting our NDA for VivaGel® BV. Starpharma is one of very few Australian companies to have achieved an NDA submission. It is very satisfying strategically that we have retained the commercial rights to VivaGel® BV, while developing the product from discovery through to the successful phase 3 trials and NDA submission – in doing so we’ve maximised its commercial value.”
I like the last bit ... hehe
Ann: NDA submission for VivaGel BV in the US, page-5
-
- There are more pages in this discussion • 33 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
